Gene · 9133
Papers2,908
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,908
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of a highly potent and orally available importin-β1 inhibitor that overcomes enzalutamide-resistance in advanced prostate cancer. | Acta Pharm Sin B | 2023 | 38045040 | PubTator, text mining | PubMed |
| Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment. | Int J Nanomedicine | 2023 | 38026523 | PubTator, text mining | PubMed |
| Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer. | Cell Death Dis | 2023 | 38012214 | PubTator, text mining | PubMed |
| Transcriptome Changes in Glioma Cells upon Infection with the Oncolytic Virus VV-GMCSF-Lact. | Cells | 2023 | 37998351 | PubTator, text mining | PubMed |
| Identification and immune landscape analysis of fatty acid metabolism genes related subtypes of gastric cancer. | Sci Rep | 2023 | 37993654 | PubTator, text mining | PubMed |
| CKAP4 and mutant p53 cooperatively abrogate cell cycle checkpoint to induce genotoxic resistance in ovarian cancer. | Clin Transl Med | 2023 | 37983936 | PubTator, text mining | PubMed |
| Loss of p53-DREAM-mediated repression of cell cycle genes as a driver of lymph node metastasis in head and neck cancer. | Genome Med | 2023 | 37978395 | PubTator, text mining | PubMed |
| Dexamethasone prophylaxis protects from acute high-altitude illness by modifying the peripheral blood mononuclear cell inflammatory transcriptome. | Biosci Rep | 2023 | 37975243 | PubTator, text mining | PubMed |
| HDAC activity is dispensable for repression of cell-cycle genes by DREAM and E2F:RB complexes. | bioRxiv | 2023 | 37961464 | PubTator, text mining | PubMed |
| Network based approach to identify interactions between Type 2 diabetes and cancer comorbidities. | Life Sci | 2023 | 37949208 | PubTator, text mining | PubMed |
| Lung cancer organoids: models for preclinical research and precision medicine. | Front Oncol | 2023 | 37941550 | PubTator, text mining | PubMed |
| HMGB2 is a potential diagnostic marker and therapeutic target for liver fibrosis and cirrhosis. | Hepatol Commun | 2023 | 37930124 | PubTator, text mining | PubMed |
| Prognostic model of hepatocellular carcinoma based on cancer grade. | World J Clin Cases | 2023 | 37900243 | PubTator, text mining | PubMed |
| Inflammation-Related Immune-Modulatory SLURP1 Prevents the Proliferation of Human Colon Cancer Cells, and Its Delivery by Salmonella Demonstrates Cross-Species Efficacy against Murine Colon Cancer. | Pharmaceutics | 2023 | 37896222 | PubTator, text mining | PubMed |
| Regulation of self-renewal and senescence in primitive mesenchymal stem cells by Wnt and TGFβ signaling. | Stem Cell Res Ther | 2023 | 37880755 | PubTator, text mining | PubMed |
| Transcriptomic analysis identifies lactoferrin-induced quiescent circuits in neonatal macrophages. | Front Immunol | 2023 | 37868991 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals molecular mechanisms of lymphocystis formation caused by lymphocystis disease virus infection in flounder (Paralichthys olivaceus). | Front Immunol | 2023 | 37868974 | PubTator, text mining | PubMed |
| Proteomics, Transcriptomics, and Phosphoproteomics Reveal the Mechanism of Talaroconvolutin-A Suppressing Bladder Cancer via Blocking Cell Cycle and Triggering Ferroptosis. | Mol Cell Proteomics | 2023 | 37866481 | PubTator, text mining | PubMed |
| BUB1, BUB1B, CCNA2, and CDCA8, along with miR-524-5p, as clinically relevant biomarkers for the diagnosis and treatment of endometrial carcinoma. | BMC Cancer | 2023 | 37853361 | PubTator, text mining | PubMed |
| Identification of transcriptome characteristics of granulosa cells and the possible role of UBE2C in the pathogenesis of premature ovarian insufficiency. | J Ovarian Res | 2023 | 37848988 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9133/papers?page=10